Meeting
2018 Cancer Survivorship Symposium
Lung screening in head and neck cancer survivors.
Authors
Avigayil East
Rush University, Chicago, IL
Avigayil East , Susan Swider
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment
Track
Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy
Sub Track
Detection of Recurrence and Secondary Malignancies
Citation
J Clin Oncol 36, 2018 (suppl 7S; abstr 179)
DOI
10.1200/JCO.2018.36.7_suppl.179
Abstract #
179
Poster Bd #
D17
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Tobacco retail availability and tobacco cessation in lung and head and neck (HN) cancer survivors.
First Author: Lawson Eng
Poster
2023 ASCO Annual Meeting
Clinical validation of an activity-based enzyme assay for early stage lung cancer.
First Author: Paul W. Dempsey
Poster
2022 ASCO Quality Care Symposium
Lessons learned from a lung cancer screening patient navigation program at a safety-net hospital system.
First Author: Andrea R Semlow
Poster
2021 ASCO Annual Meeting
One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst Hispanic/LatinX and African Americans.
First Author: Coral Olazagasti